Proxima Clinical Research Client, Airway Shield™, Receives STeP Designation for Endotracheal Intubation Device that Protects Patients and Clinicians

3 years ago

Device reduces the spread of infection from patients to clinicians during aerosol generating procedures like intubation of COVID-19 patients, among…

Bulletin From The 2022 Annual General Meeting Of Spago Nanomedical Ab (Publ)

3 years ago

LUND, SE / ACCESSWIRE / May 18, 2022 / Spago Nanomedical (STO:SPAGO.ST) (FRA:7UX.F)The Annual General Meeting (AGM) of Spago Nanomedical…

Altamira Therapeutics Issues Shareholder Letter

3 years ago

Highlights Company's progress to becoming a pure-play RNA business and tech strategy and penetrate the multi-billion TAMHAMILTON, BERMUDA / ACCESSWIRE…

Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022

3 years ago

Reports Positive Net Income of $0.2 Million and $1.2 Million of EBITDA for the First Quarter of 2022CHICAGO, IL /…

Sorrento Therapeutics, Inc. Appoints Former Roche Executive Tammy Reilly to the Board of Directors

3 years ago

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc (Nasdaq: SRNE, “Sorrento”), a commercial and clinical-stage biopharmaceutical company dedicated…

Capricor Therapeutics to Present at the H.C. Wainwright Global Investment Conference

3 years ago

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of…

FDA grants Orphan Drug Designation for tasquinimod in myelofibrosis

3 years ago

  Lund May 18, 2022 - Active Biotech AB (Nasdaq Stockholm: ACTI) today announced that the U.S. Food and Drug Administration…

Grow Therapy Survey Reveals 97% of Therapists Say the Number of People Seeking Therapy Post-Pandemic for the First Time has Increased

3 years ago

Social Media Plays a Role in Damaging One’s Mental Health, but Therapists Say News Consumption is Even Worse 1:1 Time…

Ceapro Inc. Reports Record Financial Results for First Quarter 2022 and Provides Corporate Update

3 years ago

– Best quarterly financial results in history of the Company – Q1 2022 sales of $6,172,000 vs $4,702,000 in Q1…

INmune Bio, Inc. to Present at the H.C. Wainwright Global Hybrid Investment Conference on May 24th

3 years ago

Boca Raton, FL, May 18, 2022 (GLOBE NEWSWIRE) -- INmune Bio (NASDAQ: INMB), a clinical stage immunology company focused on…